Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostate Cancer Metastatic × enzalutamide × Clear all

Phase

Phase 2 4 Phase 3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Prostatic Neoplasms, Castration-Resistant 2 Seizures 1 Prostate Cancer Metastatic 1 Primary Dysautonomias 1 Neoplasm Metastasis 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Kidney Diseases 1 Hypertension 1 Dementia 1 Cognitive Dysfunction 1

Interventions

Prednisone 2 enzalutamide 1 cabazitaxel 1 Prednisolone 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02485691 2022-05-27

CARD

Sanofi

Phase 4 Completed

255 enrolled 21 charts

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡